I am excited and honored to have been given the opportunity to update 100 Questions and Answers About Ovarian Cancer. This edition reflects some important advances in the screening, diagnosis, and treatment of ovarian cancer, as well as a more nuanced approach to topics related to life with or after ovarian cancer.
Books on ovarian cancer are important, because the disease is still so terrifying. Most women and their loved ones fear the worst at the point of diagnosis. However, we have made strides in our understanding of this disease, and this extends to how we approach its management. Today, ovarian cancer can be treated with curative intent. Even for women who relapse, longevity can be measured in many months and into years. This has come about because of researchers, patients, and their advocates- all of whom are committed to improving the lives of women diagnosed, all while aiming to prevent and then cure this cancer.
Important updates include:
- Introducing the new staging system for ovarian cancer, as published by the International Federation of Gynecology and Obstetrics (FIGO)
- Novel therapeutics including bevacizumab and olaparib
- Discussion of promising screening tools, such as the Risk of Ovarian Cancer Algorithm (ROCA)
- More information on issues focused on quality of life.
We have retained the important and still relevant information previously contributed by my colleague and friend, Nadeem Abu-Rustum, particularly as it relates to the surgical approach to this disease. More importantly, this edition brings in the fresh perspective of Dee Sparacio, who is a tireless advocate for gynecologic cancers as well as an ovarian cancer survivor herself. Along with Dee, we hope the book provides useful information about this disease, and highlights the progress we have made in a field where there is still so much more work to do.
Post written by Don S. Dizon, MD, FACP